Jonathan H. Kaufman - Jan 28, 2025 Form SCHEDULE 13D/A Schedule Report for Lipella Pharmaceuticals Inc. (LIPO)

Filing Manager: Kaufman Jonathan H
Reporting Manager: Jonathan H. Kaufman
Security: Lipella Pharmaceuticals Inc. Common Stock, par value $0.0001 per share
Symbol: LIPO
Shares outstanding: 2.1M shares
Disclosed Ownership: 212K shares
Ownership: 10.1%
Form type: SCHEDULE 13D/A
Date filed: 1/30/2025, 05:27 PM
Date of event: Jan 28, 2025
Previous filing: Jan 23, 2025
Next filing: Feb 10, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Jonathan H. Kaufman	10.1%	212K	212K	0	/s/ Jonathan H. Kaufman	Jonathan H. Kaufman	0001959250